1 / 6

Global Companion Diagnostics Market worth $6.51 Billion by 2022

The global companion diagnostics market is expected to reach USD 6.51 billion by 2022 from USD 2.17 billion in 2016, at a CAGR of 20.1%.

ritikatyagi97
Download Presentation

Global Companion Diagnostics Market worth $6.51 Billion by 2022

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. MarketsandMarkets Presents Companion Diagnostics Market - Global Forecasts to 2022 https://www.marketsandmarkets.com/Market-Reports/companion-diagnostics-market-155571681.html

  2. • The global Companion Diagnostics market is projected to reach USD 6.51 Billion by 2022 from USD 2.61 Billion in 2017, at a CAGR of 20.1%. The growth of market is majorly driven by the factors such as improvements in regulatory guidelines, growing need for targeted therapies, rising cancer incidence across the globe, and increasing collaborations and partnerships for companion diagnostics test development. • On the basis of technology, the companion diagnostics market is broadly segmented into polymerase chain reaction (PCR), in situ hybridization (ISH), immunohistochemistry (IHC), next-generation sequencing (NGS), and other technologies. In 2016, the polymerase chain reaction (PCR) segment accounted for the largest share of this market and the next-generation sequencing (NGS) segment is expected to register the highest CAGR during the forecast period. The large share of the PCR segment is attributed to its ease of use and to the fact that it does not require many samples for biomarker identification. https://www.marketsandmarkets.com/Market-Reports/companion-diagnostics-market-155571681.html

  3. https://www.marketsandmarkets.com/Market-Reports/companion- diagnostics-market-155571681.html Early buyers will receive 10% customization on reports. Geographically, the global Companion Diagnostics market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. In 2016, North America dominated the market, and this is primarily attributed to the presence of a structured regulatory framework in the region, large number of drug development activities, and the development and launch of several companion diagnostic products in recent years. The Asia-Pacific region is expected to witness the highest CAGR during the forecast period, owing to the growing need of tailored therapeutics for the elderly population; increasing number of hospitals and diagnostic laboratories; and growing prevalence of life-threatening diseases are driving the growth of the market in this regional segment. https://www.marketsandmarkets.com/Market-Reports/companion-diagnostics-market-155571681.html

  4. • Based on the indication, the global companion diagnostics market is divided into oncology, infectious diseases, neurology, and other indications. The oncology segment is expected to account for the largest share of the global companion diagnostics market by indication. It is also the fastest growing segment owing to the increasing cases of cancer cases across the globe and the rising number of clinical trials targeting cancer biomarkers for lung, breast, and prostate cancers. • On the basis of products & services, the market is segmented into assay kits, reagents, and software & services. The assay kits & reagents segment is accounted for largest share of this market in 2016. The large share of this segment can primarily be attributed to its wide range of applications in varied technology platforms. Companion diagnostic assays help eliminate the risk of severe side effects of non-targeted therapies on patients. https://www.marketsandmarkets.com/Market-Reports/companion-diagnostics-market-155571681.html

  5. Contact Us Mr. Shelly Singh MarketsandMarkets™ INC. 630 Dundee Road Suite 430 Northbrook, IL 60062 USA : 1-888-600-6441 Email: sales@marketsandmarkets.com MarketsandMarkets Blog http://www.linkedin.com/company/marketsandmarkets http://twitter.com/marketsmarkets https://www.marketsandmarkets.com/Market-Reports/companion-diagnostics-market-155571681.html

  6. About MarketsandMarkets MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world. MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. They cover thirteen industry verticals, including advanced materials, automotives and transportation, biotechnology, chemicals, consumer goods, energy and power, food and beverages, industrial automation, medical devices, electronics, and telecommunications and IT. banking and financial services, pharmaceuticals, semiconductor and We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository. https://www.marketsandmarkets.com/Market-Reports/companion-diagnostics-market-155571681.html

More Related